Published • loading... • Updated
Development and bioavailability modulation of once-daily controlled release apixaban tablets by utilizing functional pharmaceutical excipients
Summary by Pharma Excipients
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Development and bioavailability modulation of once-daily controlled release apixaban tablets by utilizing functional pharmaceutical excipients
Abstract The aim of this study was to develop a once-daily controlled-release (CR) apixaban (APX) formulation that enhances bioavailability through dual mechanisms of P-glycoprotein (P-gp) inhibition and sustained drug release using selected functional pharmaceutical excipients. Based on the screening of pharmaceutical excipients with enhanced solubility and P-gp inhibitory properties for APX, CR formulations containing polyethylene oxide (PEO 1…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
